Sattaru said they expedited the launch of Libre in India given the pandemic and the convenience of managing diabetes remotely. Abbott is expected to launch its software to collate this data on smart devices in 2021. “The reader stores the glucose values for up to 90 days, the sensor for eight hours,” he said.įor now, Indian patients will be able to see the data from the reader on the device only. Plus, the readers also shows a digital logbook, an insulin dosage calculator and average glucose levels for seven, 14, 30 and 90-day periods. Since using the sensor all then time can be an expensive proposition, the strip monitor can be used in the intervals when the sensor is not being used. “The reader also functions as a blood glucose strip monitor and a blood keto strip monitor in addition to the sensor,” Sattaru said. Sattaru said the reader shows the time in range, as set by the health care professionals, as well as the number of hypoglycaemic episodes. “The new reporting system will certainly help prevent the serious complications and death in a greater number of subjects with diabetes,” said Dr Kesavadev. His Thiruvananthapuram-based Jothydev’s Diabetes Research Centre had come up with the first-ever research from India on T1R and its correlation with HbA1c. “While the traditional HbA1c is very useful in deciding the success in diabetes care, it is only an average of three months’ blood glucose values and does not give an idea on the direction of change of glucose or the duration which is spent in normal, high or low glucose levels,” explained Dr Jothydev Kesavadev. Buy 2-year plan with SD20 code for special priceĮarlier this year, the American Diabetes Association (ADA) had endorsed the use of Ambulatory Glucose Profile (AGP) or Time in Range (T1R) report to be integrated into the management of all types of diabetes.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |